{"schema_version":"secwatch.filing_event.v1","accession":"0001999371-25-018108","form_type":"8-K","ticker":"TNXP","cik":"0001430306","company_name":"Tonix Pharmaceuticals Holding Corp.","filed_at":"2025-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.393163+00:00","generated_at":"2026-05-16T18:44:39.525026+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Tonix Pharma expands share repurchase program by $25M to $35M total authorized","bullets":["Board approved an additional $25.0 million for share repurchases, raising total authorized to $35.0 million.","Repurchases may occur from time to time in open-market or private transactions depending on conditions.","The original $10 million authorization was increased; no expiration date or commitment to repurchase any specific number of shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001999371-25-018108","json":"https://secwatch.observer/filing/0001999371-25-018108.json","markdown":"https://secwatch.observer/filing/0001999371-25-018108.md","text":"https://secwatch.observer/filing/0001999371-25-018108.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125018108/0001999371-25-018108-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125018108/tnxp-8k_111825.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:44:39.525026+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}